Aim: The aim of this study was to assess total bile acid (TBA) levels and its impact on systolic and diastolic functions in fetuses of mothers with intrahepatic cholestasis of pregnancy (ICP) using tissue Doppler imaging (TDI), and to explore the correlation between TBA levels and fetal cardiac function. Subjects and methods: The study employed 98 pregnant women with ICP who were divided into two groups according to their bile acid levels. Fifty pregnant women without ICP represented the control group. Results: Significant differences in the myocardial tissue velocities of both mitral and tricuspid valves were found between the fetuses of mothers with ICP and TBA levels of 40 mmol/L. There was a significant increase in neonatal respiratory distress, meconium staining and neonatal TBAs in group II compared to the control group and group I. There was a correlation between maternal TBA levels and preterm delivery, APGAR scores and neonatal TBA levels at birth. There was also a positive correlation between maternal TBA and fetal myocardial tissue velocities of both mitral and tricuspid, and fetal diastolic myocardial tissue Doppler velocities. Conclusion: ICP is a very serious condition especially when maternal TBA levels are >40 mmol/L. Fetal echocardiography with tissue Doppler is a useful tool for fetal assessment in patients with ICP. It could be an indication of induction of labor in cases of ICP and bile acid levels ≥40 mol/L. Neonatal echocardiography is mandatory for follow-up and management of these neonates.
Censoring mechanisms are widely used in various life tests, such as medicine, engineering, biology, etc., as they save (overall) test time and cost. In this context, we consider the problem of estimating the unknown xgamma parameter and some survival characteristics, such as reliability and failure rate functions in the presence of adaptive type-II progressive hybrid censored data. For this purpose, the maximum likelihood and Bayesian inferential approaches are used. Using the observed Fisher information under s-normal approximation, different asymptotic confidence intervals for any function of the unknown parameter were constructed. Using the gamma flexible prior, Bayes estimators against the squared-error loss were developed. Two procedures of Bayesian approximations—Lindley’s approximation and Metropolis–Hastings algorithm—were used to carry out the Bayes estimates and to construct the associated credible intervals. An extensive simulation study was implemented to compare the performance of the different methods. To validate the proposed methodologies of inference—two practical studies using datasets that form engineering and chemical fields are discussed.
6 September 2017 in United European Gastroenterology Journal
Muscle cramps markedly affect the quality of life in cirrhotic patients with no available highly effective treatment. The aim of this study was to assess the safety and efficacy of orphenadrine in the treatment of muscle cramps in cirrhotic patients. The study enrolled 30 liver cirrhosis patients complaining of frequent muscle cramps (≥3 per week), who were randomized to receive either orphenadrine 100 mg or calcium carbonate 500 mg twice daily as a control for one month. Severity, frequency, and duration of the muscle cramps were assessed before and after treatment as well as recurrence after washout of the drug for two weeks. Side effects were recorded. One month after treatment with orphenadrine; the frequency of muscle cramps decreased significantly to 0.6 ± 0.74 per week compared to 12.53 ± 6.01 at baseline (p < 0.001), the duration of muscle cramps decreased from 1 min to 0.1 min after treatment (p < 0.001). The pain score improved significantly from a score of 8/10 to 0/10 (p < 0.001). The side effects were few, such as dry mouth, drowsiness, and nausea, with no significant difference between their occurrences in the two groups. Orphenadrine is safe and effective in treatment of muscle cramps in patients with liver cirrhosis.
A new three‐parameter extension of the generalized‐exponential distribution, which has various hazard rates that can be increasing, decreasing, bathtub, or inverted tub, known as the Marshall‐Olkin generalized‐exponential (MOGE) distribution has been considered. So, this article addresses the problem of estimating the unknown parameters and survival characteristics of the three‐parameter MOGE lifetime distribution when the sample is obtained from progressive type‐II censoring via maximum likelihood and Bayesian approaches. Making use of the s‐normality of classical estimators, two types of approximate confidence intervals are constructed via the observed Fisher information matrix. Using gamma conjugate priors, the Bayes estimators against the squared‐error and linear‐exponential loss functions are derived. As expected, the Bayes estimates are not explicitly expressed, thus the Markov chain Monte Carlo techniques are implemented to approximate the Bayes point estimates and to construct the associated highest posterior density credible intervals. The performance of proposed estimators is evaluated via some numerical comparisons and some specific recommendations are also made. We further discuss the issue of determining the optimum progressive censoring plan among different competing censoring plans using three optimality criteria. Finally, two real‐life datasets are analyzed to demonstrate how the proposed methods can be used in real‐life scenarios.
1 September 2022 in Journal of Statistics Applications & Probability